Insider · CIK 0001279473

INGENITO GARY

Reports to the SEC for 2 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001279473

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-14	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−44K sh	—	—	546,282
2025-05-14	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−44K sh	$23.63	−$1.04M	68,873
2025-05-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+44K sh	$4.64	+$204K	112,873
2025-05-13	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−200K sh	$23.68	−$4.74M	68,873
2025-05-13	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+200K sh	$3.42	+$684K	268,873
2025-05-13	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−200K sh	—	—	590,282
2025-03-06	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−180K sh	—	—	790,282
2025-03-06	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+180K sh	$2.24	+$403K	248,969
2025-03-06	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−180K sh	$21.67	−$3.9M	68,873
2025-03-05	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−44.9K sh	—	—	970,378
2025-03-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+44.9K sh	$2.24	+$101K	113,777
2025-03-05	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−44.9K sh	$22.09	−$992K	68,873
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+10K sh	—	—	71,308
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−10K sh	—	—	1,015,282
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−2,435 sh	—	—	68,873
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−3,541 sh	—	—	61,308
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−9,000 sh	—	—	1,025,282
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+9,000 sh	—	—	64,849
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−7,349 sh	—	—	1,034,282
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−2,891 sh	—	—	55,849
2024-12-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+7,349 sh	—	—	58,740
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−8,631 sh	$22.74	−$196K	54,760
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−3,369 sh	$22.67	−$76.4K	51,391
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+12K sh	$4.01	+$48.1K	63,391
2024-11-27	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−12K sh	—	—	1,041,631
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Med. & Reg. Officer	AAward	+126K sh	—	—	1,038,271
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Med. & Reg. Officer	AAward	+15.4K sh	—	—	1,053,631
2024-11-20	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−38K sh	$21.20	−$806K	51,391
2024-11-20	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+38K sh	$4.01	+$152K	89,391
2024-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−38K sh	—	—	912,575
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−100K sh	—	—	950,575
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−100K sh	$18.04	−$1.8M	51,391
2024-08-09	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+100K sh	$4.01	+$401K	151,391
2024-06-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+80K sh	$4.01	+$321K	131,391
2024-06-05	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−80K sh	—	—	1,050,575
2024-06-05	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−80K sh	$16.16	−$1.29M	51,391
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+10K sh	—	—	53,826
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−10K sh	—	—	1,130,575
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−2,435 sh	—	—	51,391
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−3,541 sh	—	—	43,826
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−9,000 sh	—	—	1,140,575
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+9,000 sh	—	—	47,367
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Med. & Reg. Officer	AAward	+22K sh	—	—	1,149,575
2023-12-08	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Med. & Reg. Officer	AAward	+154K sh	—	—	1,127,526
2023-12-06	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Chief Med. & Reg. Officer	SSale	−50K sh	$14.02	−$701K	38,367
2023-12-06	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+50K sh	$1.13	+$56.5K	88,367
2023-12-06	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	−50K sh	—	—	974,000
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+10K sh	—	—	40,802
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Med. & Reg. Officer	FTax Payment	−2,435 sh	—	—	38,367
2023-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Med. & Reg. Officer	MExercise/Conversion	+10K sh	—	—	1,024,000

Recent filings

Accepted (ET)
May 154
INGENITO GARY0001161697-25-000175
SEC(opens sec.gov)
Mar 74
INGENITO GARY0001161697-25-000089
SEC(opens sec.gov)
Feb 194
INGENITO GARY0001161697-25-000069
SEC(opens sec.gov)
Dec 314
INGENITO GARY0001161697-24-000541
SEC(opens sec.gov)
Dec 114
INGENITO GARY0001161697-24-000503
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE, SUITE 801

CORAL GABLES, FL, 33134